CRIO will be attending SCDM 2025 in Baltimore, MD from September 27th-30th.
During the conference, CRIO’s Sr. Director, Security, Corporate QA & Compliance, Marc Wartenberger, will be moderating the Regulatory Townhall on Monday, September 29th at 9:15am. This Townhall brings together global regulatory leaders to share updates on ICH E6(R3) and the FDA’s AI initiatives, offering insights into evolving compliance standards and the future of clinical research oversight. For more info on the session, click here.
CRIO’s Hannah Kulkarni will present Getting the Most from Technology to Strengthen the Patient–Site Relationship, Reduce Burden on Site Staff, and Pave the Way for the Use of AI on Monday, September 29th at 11:15am. This interactive session will share practical strategies and case studies on using modern technology to ease site staff workload, enhance the patient–site connection, and explore safe, GCP-compliant applications of AI. For more info on the session, click here.
CRIO Co-CEO Jonathan Andrus will be speaking in the session Defining the Future of Clinical Trials Post-COVID-19 on Tuesday, September 30th at 12pm. This session will explore how the pandemic reshaped trial design and execution, from decentralized approaches and remote monitoring to new lessons in data quality and regulatory flexibility. Jonathan will join fellow industry leaders to discuss how these innovations can be sustained and strengthened to build more resilient, efficient, and patient-centric clinical trial systems for the future. For more info on the session, click here.